Skip to content
Forensic Analysis · Medical Devices · as of Nov 8, 2026

Resmed Inc (RMD)

A forensic read on Resmed Inc built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

B · Sound & dependable
Forensic grade
Safe
Financial health
9.1
Distress distance
Clean
Earnings quality
24.3%
ROE
9.9%
Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Resmed Inc earns a B (Sound & dependable) forensic quality grade, and its balance-sheet distress test reads 9.1, placing it in the Safe zone. 0 forensic signals listed from the 10 signals read.

Key fundamentals

Latest Revenue$5.65B
Revenue Growth YoY+9.9%
Revenue CAGR (2yr)+9.8%
Net Margin26.9%
Free Cash Flow$1.65B
Return on Equity24.3%
Debt / Equity0.10x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Resmed Inc's actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Nov 8, 2026. Forensic signals flag probability, not certainty.

See a wrong number? Report an error with the filing it should match.